TY - JOUR
T1 - The role of oral bacteria in inflammatory bowel disease
AU - Read, Emily
AU - Curtis, Michael A.
AU - Neves, Joana F.
N1 - Funding Information:
We thank Luke Roberts, William Wade, Susan Joseph, Maggie Flak and Geraldine Jowett for their critical reading of the manuscript. We apologize to authors whose papers we could not cite due to space limitations. E.R. acknowledges a PhD fellowship from the Wellcome Trust (215027/Z/18/Z). J.F.N. acknowledges a RCUK/UKRI Rutherford Fund fellowship (MR/R024812/1). M.A.C. acknowledges an MRC grant (MR/P012175/2).
Publisher Copyright:
© 2021, Springer Nature Limited.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/10
Y1 - 2021/10
N2 - Over the past two decades, the importance of the microbiota in health and disease has become evident. Pathological changes to the oral bacterial microbiota, such as those occurring during periodontal disease, are associated with multiple inflammatory conditions, including inflammatory bowel disease. However, the degree to which this association is a consequence of elevated oral inflammation or because oral bacteria can directly drive inflammation at distal sites remains under debate. In this Perspective, we propose that in inflammatory bowel disease, oral disease-associated bacteria translocate to the intestine and directly exacerbate disease. We propose a multistage model that involves pathological changes to the microbial and immune compartments of both the oral cavity and intestine. The evidence to support this hypothesis is critically evaluated and the relevance to other diseases in which oral bacteria have been implicated (including colorectal cancer and liver disease) are discussed.
AB - Over the past two decades, the importance of the microbiota in health and disease has become evident. Pathological changes to the oral bacterial microbiota, such as those occurring during periodontal disease, are associated with multiple inflammatory conditions, including inflammatory bowel disease. However, the degree to which this association is a consequence of elevated oral inflammation or because oral bacteria can directly drive inflammation at distal sites remains under debate. In this Perspective, we propose that in inflammatory bowel disease, oral disease-associated bacteria translocate to the intestine and directly exacerbate disease. We propose a multistage model that involves pathological changes to the microbial and immune compartments of both the oral cavity and intestine. The evidence to support this hypothesis is critically evaluated and the relevance to other diseases in which oral bacteria have been implicated (including colorectal cancer and liver disease) are discussed.
UR - http://www.scopus.com/inward/record.url?scp=85113194211&partnerID=8YFLogxK
U2 - 10.1038/s41575-021-00488-4
DO - 10.1038/s41575-021-00488-4
M3 - Review article
AN - SCOPUS:85113194211
SN - 1759-5045
VL - 18
SP - 731
EP - 742
JO - Nature Reviews Gastroenterology and Hepatology
JF - Nature Reviews Gastroenterology and Hepatology
IS - 10
ER -